Renin–angiotensin system inhibition and risk of infection and mortality in COVID‐19: a systematic review and meta‐analysis

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of COVID‐19, enters human cells by binding of its viral protein to the aminopeptidase angiotensin‐converting enzyme 2 (ACE2). This has led to speculation whether treatment with renin–angiotensin system (RAS...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Intern Med J
Main Authors: Koshy, Anoop N., Murphy, Alexandra C., Farouque, Omar, Ramchand, Jay, Burrell, Louise M., Yudi, Matias B.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons Australia, Ltd 2020
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753674/
https://ncbi.nlm.nih.gov/pubmed/33191600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imj.15002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares